A follow-up study by the same group investigating hormone receptor expression in a small cohort of low grade serous ovarian cancer (n = 26) did not observe a relationship with FSHR expression and patient survival [16]. This evidence concerns the gene NR4A1 and ovarian serous adenocarcinoma.